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Protein N-glycosylation in eukaryotes and peptidoglycan
biosynthesis in bacteria are both initiated by the transfer of a
D-N-acetylhexosamine 1-phosphate to a membrane-bound
polyprenol phosphate. These reactions are catalyzed by a
family of transmembrane proteins known as the UDP-D-
N-acetylhexosamine: polyprenol phosphate D-N-acetylhex-
osamine 1-phosphate transferases. The sole eukaryotic mem-
ber of this family, the D-N-acetylglucosamine 1-phosphate
transferase (GPT), is specific for UDP-GlcNAc as the donor
substrate and uses dolichol phosphate as the membrane-bound
acceptor. The bacterial translocases, MraY, WecA, and
WbpL, utilize undecaprenol phosphate as the acceptor sub-
strate, but differ in their specificity for the UDP-sugar donor
substrate. The structural basis of this sugar nucleotide specific-
ity is uncertain. However, potential carbohydrate recognition
(CR) domains have been identified within the C-terminal
cytoplasmic loops of MraY, WecA, and WbpL that are
highly conserved in family members with the same UDP-N-
acetylhexosamine specificity. This review focuses on the cata-
lytic mechanism and substrate specificity of these bacterial
UDP-D-N-acetylhexosamine: polyprenol phosphate D-N-
acetylhexosamine 1-P transferases and may provide insights for
the development of selective inhibitors of cell wall biosynthesis.
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Introduction
The UDP-HexNAc: polyprenol-P HexNAc-1-P transferase
enzyme family, which includes both eukaryotic and
prokaryotic transmembrane proteins, catalyzes the biosyn-
thesis of polyprenol-linked oligosaccharides (Lehrman,
1994). These transferase-catalyzed reactions involve a
membrane-associated polyprenol phosphate acceptor and a
cytoplasmic UDP-D-N-acetylhexosamine sugar nucleotide
as the donor substrate. The eukaryotic UDP-GlcNAc:
dolichol-P GlcNAc-1-P transferase (GPT) transfers
N-acetylglucosamine-1-phosphate (GlcNAc-1-P) from
UDP-GlcNAc to the polyisoprenoid acceptor dolichol
phosphate to form GlcNAc-PP-dolichol (Lehrman, 1991;
McLachlan and Krag, 1992). This is the first committed
step in the assembly of dolichol-linked oligosaccharide
intermediates and is essential for eukaryotic protein N-glyc-
osylation (Burda and Aebi, 1999; Imperiali et al., 1999). The
prokaryotic enzymes catalyze reactions analogous to those
of the eukaryotic GPTs, but which lead to the formation of
polyprenol-linked oligosaccharides involved in bacterial
cell wall and peptidoglycan assembly (Bugg and Brandish,
1994; Anderson et al., 2000).
There are significant sequence similarities amongst the
UDP-GlcNAc/MurNAc enzyme family members (Lehrman,
1991, 1994; Anderson et al., 2000; Amer and Valvano,
2001; Bouhss et al., 2004; Lloyd et al., 2004) (Figure 1).
A series of six conserved sequences (designated A through
F) ranging from 5 to 13 amino acid residues have been iden-
tified within both the bacterial and eukaryotic members of
the family (Nogare et al., 1998). Systematic deletion of the
internal A–F microdomains results in Chinese hamster
ovary (CHO) cells that lack enzyme activity, but are still
able to bind tunicamycin, a substrate analog inhibitor
(Nogare et al., 1998). These conserved sequences all occur
at or near an interface between hydrophilic and hydrophobic
domains. Their distribution suggests a possible involvement
in substrate binding and/or catalysis because the sugar-
nucleotide donors are hydrophilic, whereas the polyprenol
acceptor is hydrophobic (Bugg and Brandish, 1994; Anderson
et al., 2000). The relative order and positions of these con-
served sequences strongly imply that this group of enzymes
constitutes a conserved family, and for that reason, they
have been termed the UDP-GlcNAc/MurNAc family
(Lehrman, 1994).
Four subgroups of bacterial enzymes have been identified
within the family based on their specific substrate preference,
MraY, WecA/TagO, WbcO/WbpL, and RgpG (Anderson
et al., 2000). These subgroups are highly homologous and
use a common, membrane-bound acceptor substrate, unde-
caprenol phosphate, but differ in their selectivity for soluble
sugar nucleotide donor. MraY-type transferases are highly
specific for UDP-N-acetylmuramate-pentapeptide (UDP-
MurNAc-pp) (Meadow et al., 1964; Hammes and Neuhaus,
1974), whereas WecA proteins are selective for UDP-
N-acetylglucosamine (UDP-GlcNAc) (Barr et al., 1989),
sugar nucleotides that differ only by the UDP-MurNAc-pp
substituent, 3-O-lactyl-pentapeptide. The WbcO/WbpL
substrate specificity has not yet been determined, but the
structure of their biosynthetic endproducts implies that
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UDP-N-acetyl-D-fucosamine (UDP-FucNAc) and/or UDP-
N-acetyl-D-quinosamine (UDP-QuiNAc) are used (Skurnik,
1999; DiGiandomenico et al., 2002; Raymond et al., 2002;
Skurnik and Bengoechea, 2003). Similar reasoning suggests
that the RgpG subgroup is composed of relatively nonspe-
cific transferases that can use either UDP-FucNAc or
UDP-GlcNAc (Shibata et al., 2002). The transferred sugar
phosphates in these transferase-catalyzed reactions are
evidently all 2-deoxy-2-N-acetyl-D-hexosamine-1-phosphates,
suggesting that it is this distinguishing structural motif that
determines the sugar nucleotide substrate specificity (Anderson
et al., 2000).
This review focuses specifically on the bacterial UDP-
HexNAc: polyprenol-P HexNAc-1-P transferases and will
discuss the MraY, WecA/TagO/Llm, WbpL/WbcO, and
RgpG subfamily members. Details of the carbohydrate
recognition (CR) domains, DDxxD Mg2+-binding motif,
and the active site nucleophile motif will be discussed.
Mechanistic and enzyme inhibitor studies are also reviewed,
with particular reference to the substrate analog inhibitor,
tunicamycin.
The MraY transferase subfamily
The D-MurNAc-pentapeptide-1-P transferase (MraY,
translocase I) is an essential and ubiquitous bacterial
enzyme that catalyzes the first membrane-associated step in
peptidoglycan biosynthesis (van Heijenoort, 2001a,b).
Peptidoglycan biosynthesis is initiated in the cytoplasm
where the precursor sugar nucleotide UDP-MurNAc-L-
Ala-D-Glu-X-D-Ala-D-Ala (where X is either m-DAP or
L-Lys) is assembled by the stepwise addition of L-alanine,
D-glutamate, and meso-diaminopimelic acid (meso-DAP) to
UDP-N-acetyl-muramic acid, followed by the addition of
the D-Ala-D-Ala dipeptide (van Heijenoort, 2001a). These
additions are catalyzed by the Mur group of enzymes and
constitute an important target for antibacterial agents
(Wong and Pompliano, 1998; Trias and Yuan, 1999;
El Zoeiby et al., 2003; Silver, 2003).
Subsequent biosynthetic steps for peptidoglycan occur at
the periplasmic membrane (van Heijenoort, 2001b). MraY
catalyzes the transfer of MurNAc-pentapeptide-1-P from
the sugar nucleotide precursor to the membrane-associated
lipid carrier (undecaprenol phosphate) to give MurNAc-
pentapeptide-PP-undecaprenol (lipid I), with release of uri-
dine monophosphate (UMP). Translocase II (MurG), an
N-acetylglucosamine-β-1,4-transferase then catalyzes the
addition of N-acetylglucosamine (GlcNAc) to lipid I to
yield GlcNAc-MurNAc-pentapeptide-PP-undecaprenol
(lipid II) and release UDP. This second transferase is
encoded by the murG gene and has been shown to be
peripherally associated with the cytoplasmic face of the
membrane (Ha et al., 2000, 2003; van den Brink-van der
Laan et al., 2003). The lipid II intermediate is then
“flipped” to the outer face of the membrane where it
becomes the initial substrate for the peptidoglycan cross-
linking reactions (van Heijenoort, 2001a,b).
The D-MurNAc-pentapeptide-1-P transferase (MraY)
belongs to the UDP-GlcNAc/MurNAc enzyme family
and has been studied in Escherichia coli (Geis and Plapp,
1978), Micrococcus lysodiekticus (Anderson et al., 1965),
and Staphylococcus aureus (Pless and Neuhaus, 1973). In
E. coli, the mraY gene encoding the transferase has been
found in the mra (murein) gene cluster and has been cloned
and sequenced (Ikeda et al., 1991). The mra region contains
genes involved in either cell division or murein synthesis.
The MraY protein is an essential enzyme, and cells depleted
of MraY first swell and then rupture (Boyle and Donachie,
1998). It is one of the most basic proteins found in bacteria
with a theoretical pI around 9.5 (Anderson et al., 2000).
Overexpression of MraY is often detrimental, and it is only
recently that E. coli MraY protein has been overexpressed
and purified (Bouhss et al., 2004; Lloyd et al., 2004).
The membrane topologies of the MraY transferases
from both the Gram-negative E. coli and Gram-positive
S. aureus have been established by protein fusion to beta-
lactamase and used to generate a common topological
model (Bouhss et al., 1999). This model was in agreement
with many structural features predicted from the compara-
tive sequence analysis of 25 other MraY proteins, which
confirmed its validity as a topological model for all eubac-
terial MraYs (Bouhss et al., 1999). Putative MraY proteins
contain 10 transmembrane domains, with the N- and C-termini
exposed on the periplasm face of the bacterial membrane.
Five cytoplasmic loops (designated cytoloop I–V) and four
periplasmic loops (designated exoloop I–IV) are apparent,
the topology and distribution of which are highly con-
served in other MraY subfamily members (Bouhss et al.,
1999; Anderson et al., 2000; Amer and Valvano, 2001,
2002) (Figure 1).
Fig. 1. Conserved functional domains for the MraY/WecA/WbcO 
transferase family. The postulated active site Asp nucleophile (V/IFMGD 
motif) and the Mg2+-cofactor binding site (DD) are highlighted in red. 
The cytoplasmic domains (cytoloops I–V) are indicated (bold underline) 
with the most highly conserved motifs boxed in yellow. The postulated 
carbohydrate recognition (CR) domains are located on cytoloop V. 
Calculated isoelectric points (pI) for the entire sequences and their N- and 
C-terminal distribution are as shown. Basic residues are shown in blue.
MraY_ECOLI (overall pI = 9.65):-
MLVWLAEHLV KYYSGFNVFS YLTFRAIVSL LTALFISLWM N/C-term. pI’s
GPRMIAHLQK LSFGQVVRND GPESHFSKRG TPTMGGIMIL
TAIVISVLLW AYPSNPYVWC VLVVLVGYGV IGFVDDYRKV pI = 9.43
VRKDTKGLIA RWKYFWMSVI ALGVAFALYL AGKDTPATQL
VVPFFKDVMP QLGLFYILLA YFVIVGTGNA VNLTDGLDGL
AIMPTVFVAG GFALVAWATG NMNFASYLHI PYLRHAGELV
IVCTAIVGAG LGFLWFNTYP AQVFMGDVGS LALGGALGII
AVLLRQEFLL VIMGGVFVVE TLSVILQVGS FKLRGQRIFR pI = 11.31
MAPIHHHYEL KGWPEPRVIV RFWIISLMLV LIGLATLKVR
WecA_ECOLI (overall pI = 10.01):- 
MNLLTVSTDL ISIFLFTTLF LFFARKVAKK VGLVDKPNFR
KRHQGLIPLV GGISVYAGIC FTFGIVDYYI PHASLYLACA
GVLVFIGALD DRFDISVKIR ATIQAAVGIV MMVFGKLYLS pI = 8.35
SLGYIFGSWE MVLGPFGYFL TLFAVWAAIN AFNMVDGIDG
LLGGLSCVSF AAIGMILWFD GQTSLAIWCF AMIAAILPYI
MLNLGILGRR YKVFMGDAGS TLIGFTVIWI LLETTQGKTH
PISPVTALWI IAIPLMDMVA IMYRRLRKGM SPFSPDRQHI pI = 11.44
HHLIMRAGFT SRQAFVLITL AAALLASIGV LAEYSHFVPE
WVMLVLFLLA FFLYGYCIKR AWKVARFIKR VKRRLRRNRG
GSPNLTK
WbcO Yersinia (overall pI = 8.63):- 
MPTFFFLLTI FFLASVGLTY LLRLYALKNN IIDTPNSRSS
HVTPTPRGGG VAIVISFLIG MILFYFLGYL PILSAVGLIV
SGGVIALVGF WDDHGHIAAR WRLLAHFSAA AFLLFCLGGF pI = 6.14
PVLKVSDFII DLGIFGSLFG LLFLVWMLNL YNFMDGIDGL
ASAQAVTACL GMIAIYYISG DHIELNSYLV LWLLACTVLG
FLLWNFPPAK IFMGDAGSGF LGLMIGSLAI SAGWIETKFF
FCWLILLGVF IVDATWTLVR RVLGGFKAYE AHRSHGYQIA pI = 9.73
SRKFKRHLPV TLSTIAINII WLFPIALLVG LNIVNPIIAL
IISYTPILYI DYKLNAGVNN D
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The MraY proteins generally contain either 324 or 360
amino acid residues. The Bacillus subtilis MraY protein is
typical of the 324 amino acid type, and the E. coli MraY of
the longer, 360 amino acid type. The major differences
between the two types occur at the N-terminus (Figure 2).
The 324 amino acid type MraYs have only 3–5 periplasmi-
cally located residues before the first transmembrane domain.
In addition, the 324 amino acid type lacks a 15-residue
sequence that maps to the third periplasmic loop (Figure 2).
Exceptions to these two general types are the unusually
large MraYs of Bacteroides species (typically 419 amino
acid, 47 kDa) and the smaller MraY homolog (Q6W3M8,
149 amino acid, 16.7 kDa) of Alvinella pompejana epibiont
6C6, a symbiont from a deep-sea polychaete that colonizes
tubes on the sides of black smoker chimneys. This latter
gene encodes a putative MraY protein with close homology
to 360 amino acid type mraY’s at the C-terminus, but lacks
the N-terminal domains (Figure 2). It is adjacent to a gene
with homology to murD (UDP-MurNAc-Ala-D-Glu ligase)
with just nine nucleotides separating start and finish sites
(Campbell et al., 2003).
Hydrophobity profiling indicates that the larger Bacteroi-
des MraY’s are still comprised of 10 transmembrane (TM)
domains (N. Price, unpublished). However, two additional
sequences, LSPDVVIRENIEVQKSENEIEVIHGTH and
EHAQTAG, are inserted into the second periplasmic loop
(cytoloop II) and an extra 17 residues, SLVEPGCSVKFTK-
PDQL, are inserted into cytoplasmic loop V immediately
Fig. 2. Pileup alignment of representative MraY sequences of different lengths. Alvinella pompejana epibiont 6C6 (Q6W3M8), 149 amino acids; Bacillus 
subtilis (Q03521), 324 amino acids  Escherichia coli (P15876), 360 amino acids; and Bacteroides fragilis (Q64ZL8), 422 amino acids.
tr|Q6W3M8                 .......... .......... .......... .......... ..........  
sp|Q03521|MRAY_BACSU      .......... .......... .MLEQVILFT ILMGFLISVL LSPILIPFLR
sp|P15876|MRAY_ECOLI      MLVWLAEHLV KY.YSGFNVF SYLTFRAIVS LLTALFISLW MGPRMIAHLQ  
tr|Q64ZL8                 MLYYLFEWLH KLNFPGAGMF GYTSFRALMA IILALLISSI WGDKFINLLK  
tr|Q6W3M8                 .......... .......... .......... .......... ..........  
sp|Q03521|MRAY_BACSU      RLKFGQSIRE EGPK.SHQKK SGTPTMGGVM IILSIIVTTI VMTQKFSEIS  
sp|P15876|MRAY_ECOLI      KLSFGQVVRN DGPE.SHFSK RGTPTMGGIM ILTAIVISVL LWAYPS..N.  
tr|Q64ZL8                 RKQITETQRD AKIDPFGVNK VGVPSMGGVI IIVAILIPCL LLGKLHN...  
tr|Q6W3M8                 .......... .......... .......... .......... ..........  
sp|Q03521|MRAY_BACSU      PEMVLLLFVT LGYGLLGFLD DYIKVVMKRN LGLTSKQKLI GQIIIAV.VF  
sp|P15876|MRAY_ECOLI      PYVWCVLVVL VGYGVIGFVD DYRKVVRKDT KGLIARWKYF WMSVIALGVA  
tr|Q64ZL8                 IYMILMLITT VWLGSLGFAD DYIKIFKKDK EGLHGKFKII GQVGLGLIVG  
tr|Q6W3M8                 .......... .......... .......... .......... ..........  
sp|Q03521|MRAY_BACSU      YAVYHY.... .......... .......... .YNFATDIRI PG........  
sp|P15876|MRAY_ECOLI      FALYLAG... .......... .......... KDTPATQLVV PFF.......  
tr|Q64ZL8                 LTLYLSPDVV IRENIEVQKS ENEIEVIHGT HDLKSTQTTI PFFKSNNLDY  
tr|Q6W3M8                 .......... .......... .......... .......... ..........  
sp|Q03521|MRAY_BACSU      TDLSFDLG.. .....WAYFI LV.LFMLVGG SNAVNLTDGL DGLLSGTAAI  
sp|P15876|MRAY_ECOLI      KDVMPQLG.. .....LFYIL LA.YFVIVGT GNAVNLTDGL DGLAIMPTVF  
tr|Q64ZL8                 ADLVGFMGEH AQTAGWILFV IITIFVVTAV SNGANLNDGM DGMAAGNSAI  
tr|Q6W3M8                 ....MAIIVY ITGNYVLSKY LLLPNIGGVG EITVLASSLS GALFGFLWYN  
sp|Q03521|MRAY_BACSU      AFGAFAILAW NQSQYDVA.. .......... ...IFSVAVV GAVLGFLVFN  
sp|P15876|MRAY_ECOLI      VAGGFALVAW ATGNMNFASY LHIPYLRHAG ELVIVCTAIV GAGLGFLWFN  
tr|Q64ZL8                 IGLTLGILAY VSSHIEFAGY LNIMYIPGSE ELVIFICAFI GALIGFLWYN  
tr|Q6W3M8                 CYPAELFMGD TGSLSIGGVI AYMAILAKSE FLLLLIGFIF VIETISVIVQ  
sp|Q03521|MRAY_BACSU      RDPAKVFMGD TGSLALGGAI VTIAILTKLE ILLVIIGGVF VIETLSVILQ  
sp|P15876|MRAY_ECOLI      TYPAQVFMGD VGSLALGGAL GIIAVLLRQE FLLVIMGGVF VVETLSVILQ  
tr|Q64ZL8                 AYPAQVFMGD TGSLTIGGII AVFAIIIHKE LLIPILCGIF LVENLSVLLQ  
tr|Q6W3M8                 VGSYKVRQK. ....RIFLMA PIHHHFEMKQ .......... .......WAE  
sp|Q03521|MRAY_BACSU      VISFKTTGK. ....RIFKMS PLHHHYELVG .......... .......WSE  
sp|P15876|MRAY_ECOLI      VGSFKLRGQ. ....RIFRMA PIHHHYELKG .......... .......WPE  
tr|Q64ZL8                 RFYYKAGKRK GIKQRLFKRA PIHDHFRTSM SLVEPGCSVK FTKPDQLFHE  
tr|Q6W3M8                 NKIIVRFWMV AFVANILALI TIKIR 
sp|Q03521|MRAY_BACSU      WRVVVTFWAA GLLLAVLGIY IEVWL 
sp|P15876|MRAY_ECOLI      PRVIVRFWII SLMLVLIGLA TLKVR 
tr|Q64ZL8                 SKITVRFWIV TIVLAAITII TLKIR 
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after the CR domain (Figure 2). The Bacteroides MraYs are
also amongst the least conserved within the CR domain
itself, with the sequence RAPIHDHFRT in place of the usu-
ally highly conserved MAPIHHHFEL (note particularly the
His-Asp-His instead of the usual triple-His motif). Also less
conserved in this region are the glutamine-containing
MAPLQHHFEL motifs of Streptomyces coelicolor and
Streptomyces avermitilis (P56833 and Q82AD9, respec-
tively); the CSPLHHHYEY motif characteristic of Chlamy-
dia species; the MAPFHHHFE motif of mycobacterial
MraYs; and, in several miscellaneous bacteria, the replace-
ment of the Pro by a fourth His residue, that is, MAHLHH-
HFEL. Interestingly, the atypical MraY CR motif in
mycobacterial species, with Phe replacing the usual Leu/Ile at
position 4, correlates with their N-glycolylated peptidogly-
can (Raymond et al., 2005), suggesting that this replacement
may extend the MraY substrate specificity to include UDP-
MurN-glycolyl-pentapeptide substrates.
The enzyme kinetics of S. aureus (Copenhagen) MraY
have been studied in detail (Heydanek et al., 1969). The
reaction pathway occurs by a double displacement mecha-
nism according to the following sequence:
UDP-MurNAc-pentapeptide + MraY-Nuc+ → MraY-
MurNAc-pentapeptide + UMP (step 1)
MraY-MurNAc-pentapeptide + undecaprenol-P → MraY +
MurNAc-pentapeptide-PP-undecaprenol (step 2)
The first reaction (step 1) involves the formation of an
acyl-enzyme intermediate, due to a nucleophilic attack by
an active site residue on the sugar nucleotide alpha
phosphate. The leaving group for this reaction is UMP.
Note also that step 1 is reversible (Pless and Neuhaus,
1973), and that this UMP exchange reaction has been used
as the basis for several MraY activity assays (Geis and
Plapp, 1978; Zawadzke et al., 2003; Bouhss et al., 2004).
Step 1 is competitively inhibited in the forward direction by
5-fluoro-UDP-MurNAc-pentapeptide (Ki = 0.12 mM) and
in the reverse, exchange reaction by 5-fluoro-UMP (Ki =
50 µM) (Stickgold and Neuhaus, 1967). The second reac-
tion (step 2) involves the displacement of the acyl-enzyme
intermediate with transfer of the D-MurNAc-pentapeptide-
1-P group to the membrane-bound undecaprenol phos-
phate. The product of this reaction, D-MurNAc-pentapep-
tide-PP-undecaprenol (lipid I), represents the first
membrane-bound intermediate in the biosynthesis of pepti-
doglycan (Neuhaus, 1970; van Heijenoort, 2001b).
MraY substrate specificity
The MraY sugar nucleotide substrate, UDP-MurNAc-
pentapeptide, may vary in the composition of its 3-O-lactyl
pentapeptide substituent. The pentapeptide most often has
a DAP residue in position 3 as in E. coli or a lysine residue
as in S. aureus (Hammes and Neuhaus, 1974; Bouhss et al.,
1999). However, complementation analyses have shown
that the S. aureus MraY is functional in E. coli (Bouhss
et al., 1999). This tolerance of MraY toward different pep-
tide moieties in the nucleotide substrate shows a low speci-
ficity of the enzyme for the peptide side chain. MraY has
been shown to accept shorter or longer peptides as well as
modified peptides as substrates: dipeptides (Ornelas-Soares
et al., 1994), tripeptides (Hammes and Neuhaus, 1974;
van Heijenoort et al., 1992), tetrapeptides (Hammes and
Neuhaus, 1974), acetylated and dansylated pentapeptides
(Ward and Perkins, 1974; Weppner and Neuhaus, 1977;
Brandish et al., 1996a, b; Stachyra et al., 2004), and hexa-
and heptapeptides (Billot-Klein et al., 1997).
The S. aureus MraY is selective for its native precursor,
UDP-MurNAc-Ala-D-Glu-Lys-D-Ala-D-Ala, and there is
high specificity for L-Ala in position 1 and the D-Ala at
position 4 (Hammes and Neuhaus, 1974). Replacement of
both L-Asp-1 and D-Asp-4 by glycine reduced the S. aureus
MraY Vmax/Km by 135-fold (Hammes and Neuhaus,
1974). UDP-MurNAc-tetrapeptide, lacking the outermost
D-Ala, or UDP-MurNAc-tripeptide were 4-fold and 77-
fold, respectively, less active than the native substrate. The
UDP-MurNAc-tripeptide rate is characterized by a high
Km and at higher concentration is comparable to that of
the native substrate. The rate of transfer from 5-fluoro-
UDP-MurNAc-pentapeptide is <2% of that observed with
the native substrate (Stickgold and Neuhaus, 1967;
Neuhaus, 1970), and 5-fluoro-UDP-MurNAc-pentapeptide
is a competitive inhibitor (Ki = 1.2 × 10–4 M) in the transfer
reaction (Neuhaus, 1970). 4-Fluorinated UDP-MurNAc
pentapeptide has also been synthesized and inhibits the
growth of gram-positive bacteria in culture when added at
0.01 mg/mL (Ueda et al., 2004).
The specificity of the MraY-catalyzed UMP exchange
reaction has also been studied. 5-Fluoro-UMP is a com-
petitive inhibitor (Ki = 5 × 10–4 M) of the exchange
reaction (Stickgold and Neuhaus, 1967). When 5-fluoro-
UMP is used in the exchange reaction, the rate is <0.5% of
that observed with UMP. It was also observed that UDP-
MurNAc-Ala-D-Glu-Lys-D-Ala-Gly is a moderate competi-
tive inhibitor of the transferase reaction (Ki = 0.84 mM),
indicating that the analogs interact at the same binding
site(s) (Stickgold and Neuhaus, 1967). UDP-MurNAc-
tripeptide is also a poor substrate for the UMP exchange
reaction, 150-fold less active than UDP-Mur-pentapeptide
(Neuhaus, 1970). In peptidoglycan of other bacteria, the
Lys residue at position 3 is often replaced by DAP, and
indeed, the S. aureus MraY enzyme has low specificity for
this substitution (Hammes and Neuhaus, 1974). This lack
of specificity for the diamino acid residue has been
exploited in fluorescence-based MraY assays that use
UDP-MurNAc-pentapeptide dansyl substituted on the
Lys/DAP amino group (Brandish et al., 1996a; Stachyra
et al., 2004). Quenching experiments with this fluorescent
substrate show that the dansyl group is located in vivo close
to the membrane interface (Weppner and Neuhaus, 1978).
The specificity of E. coli MraY for the polyprenol
phosphate substrate has also been studied. The preferred
substrate is the natural one, undecaprenol-P, although
the enzyme can also accept heptaprenyl phosphate (C35)
and dodecaprenyl phosphate (C60) as substrates
(Brandish et al., 1996a). The ability of MraY to use the
eukaryotic lipid carrier, dolichol-P, has not as yet been tested,
but the bacterial GlcNAc-1-P transferase WecA is unable to
utilize dolichol-P as a lipid carrier (Rush et al., 1997).
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The WecA/TagO/Llm transferase subfamily
The wecA gene (formerly called rfe) specifies the UDP-
GlcNAc: undecaprenol phosphate GlcNAc-1-P transferase
(WecA) that catalyzes the first step in the biosynthesis of
enterobacterial common antigen (ECA) (Schmidt et al.,
1976; Meier-Dieter et al., 1992) and lipopolysaccharide (LPS)
O-antigen (Schmidt et al., 1976; Alexander and Valvano,
1994; Rick et al., 1994). ECA is a glycolipid produced by all
members of the Enterobacteriaceae (Barr and Rick, 1987;
Meier-Dieter et al., 1992). The early steps in the biosynthe-
sis of ECA involve the assembly of the initial sugar repeat
unit onto undecaprenol phosphate, to yield a lipid-linked
intermediate (Rick et al., 1985; Barr and Rick, 1987). The
genetic determinants of the ECA biosynthesis are located in
the rfe–rff gene cluster on the E. coli chromosome and have
been characterized in E. coli mutants defective in ECA bio-
synthesis (Meier-Dieter et al., 1992). One of these genes, the
wecA (rfe) gene, is essential for the synthesis of ECA and
also for the biosynthesis of LPS O-antigen (Schmidt et al.,
1976). Escherichia coli wecA mutants lack the ability to syn-
thesize GlcNAc-PP-undecaprenol (Barr and Rick, 1987;
Meier-Dieter et al., 1992).
The general topology of WecA/TagO/Llm subfamily
members is similar to MraY and typically consists of 11
transmembrane domains (Anderson et al., 2000). However,
unlike MraY, the C-terminus of WecA is cytosolic, giving
rise to the 11th TM domain and hence to five cytoplasmic
loops and five external loops (Anderson et al., 2000). The
terminal transmembrane helix (TM-11) is essential for the
stability of the protein, perhaps because of its interactions
with other transmembrane segments or because it targets the
WecA protein to the plasma membrane (Amer and Valvano,
2000). The C-terminal region following TM-11 has a net
positive charge, further evidence for its cytosolic location
(Amer and Valvano, 2000). For the E. coli MraY and
WecA proteins, these structural differences may underlie
the different detergent requirements to maintain their activ-
ity in vitro. The E. coli WecA is active in Chaps but inacti-
vated by Triton X-100, whereas the opposite is true for
MraY activity (Umbreit and Strominger, 1972; Hyland and
Anderson, 2003), a difference that has been used to distin-
guish WecA, MraY, and MurG activities in a high-
throughput solid-phase extraction assay (Hyland and
Anderson, 2003).
Removal of the first three transmembrane domains from
the E. coli WecA protein, including the cytoplasmic and
periplasmic loops between them, results in nonfunctional
WecA enzymes (Amer and Valvano, 2000). However, these
truncated WecA mutants are still correctly inserted in the
cytoplasmic membrane, suggesting that the first N-terminal
110 amino acids of WecA are required for enzyme function
but not for membrane insertion (Amer and Valvano, 2000).
Hence, WecA may be inserted in the membrane by a sec-
independent mechanism involving residues in the middle
and/or the C-terminal part of the protein (Amer and
Valvano, 2000). A comparison of the bacterial WecA
sequences with the eukaryotic GlcNAc-1-P transferases
(GPTs) found in yeast and in CHO cells revealed overall
general similarities (Zhu and Lehrman, 1990; McLachlan
and Krag, 1992; Lehrman, 1994). The similarity and identity
of the E. coli WecA protein with the GPT from CHO cells
were 57.5 and 23.8%, respectively (Meier-Dieter et al., 1992).
Proteins in the WecA/TagO/Llm subfamily typically con-
tain 350–360 amino acids. Exceptionally large WecA
homologs are those of Pirellula baltica (Q7UQ81, 532
amino acid, 57 kDa) and Nitrosomonas europaea (Q82SN0,
540 a.a) (N. Price, unpublished). The N. europaea gene has
strong homology to the other WecA subfamily members at
the N-terminus and low similarity to SpaA, a two-component
sensor histidine kinase, at the C-terminus. The Pirellula gene
has similarity to tagO at the N-terminus (BLAST E-value
= 1e–32), but with a unique 173 amino acid C-terminal
sequence. Importantly, the predicted DDxxD Mg2+-binding
motif and the WecA-type HIHH CR motif (discussed
below) are conserved for both of these sequences (N. Price,
unpublished).
Homologs of WecA are also found in Bacillus sp. and on
the genomes of mycobacteria. Bacillus subtilis 168 tagO gene
has relatively low overall homology to E. coli wecA (BLAST
E-value = 2e–17), but has more pronounced similarity in the
CR domain. TagO is required for the biosynthesis of two
teichoic acids (TAs) in B. subtilis 168, a major TA required
for growth and a nonessential minor TA (Soldo et al., 2002).
Given the known hypersensitivity of Bacillus bacteria to
tunicamycin (Tamura et al., 1976), a nonselective inhibitor,
it is likely that TagO is a more important target than MraY
in these strains. If so, it will be interesting to compare the
tunicamycin sensitivity of Bacillus strains relative to their
sensitivity to an MraY-specific inhibitor, such as mureido-
mycin or liposidomycin. A lipophilic protein (Llm) in
S. aureus with homology to TagO affects the rate of bacterial
lysis and resistance to methicillin (Maki et al., 1994).
A global sequence alignment of the cytoplasmic domain V
within the WecA subgroup revealed a highly conserved CR
motif that is specific for the WecA enzymes (Anderson et al.,
2000). The WecA CR domain contains three conserved histi-
dine residues in close proximity, separated by a small hydro-
phobic amino acid (typically, HIHH) (Anderson et al., 2000;
Amer and Valvano, 2001, 2002). Except for their highly basic
nature and the presence of a central histidine residue, no
other significant homology has been found between the
consensus sequences in WecA and MraY. Interestingly, no
significant sequence similarity has been observed between the
bacterial WecA cytoplasmic domain V and the eucaryotic
GPT proteins, even though both enzymes transfer GlcNAc-1-
phosphate onto the lipid carrier (Anderson et al., 2000).
The WbpL/WbcO and RgpG subfamilies
The WbpL/WbcO subgroup of bacterial UDP-HexNAc:
polyprenol-P HexNAc-1-P transferases includes the WbcO
protein from Yersinia enterocolitica and the WbpL protein
from Pseudomonas aeruginosa (Dean et al., 1999; Skurnik,
1999; Anderson et al., 2000; DiGiandomenico et al., 2002;
Raymond et al., 2002). These two transferases initiate LPS
O-antigen biosynthesis as putative-D-FucNAc-1-P trans-
ferases (Rocchetta et al., 1998; Belanger et al., 1999; Anderson
et al., 2000). Similar to other GlcNAc/MurNAc-1-P trans-
ferase family members, WbpL is a highly hydrophobic
protein possessing 11 predicted transmembrane domains
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(Belanger et al., 1999; Anderson et al., 2000). The wbcO
gene (formerly called trsF) is located on the Y. enterocolit-
ica serotype 3 core 3 cluster (Skurnik, 1999; Skurnik and
Bengoechea, 2003). The gene wbpL has been found in the
O-antigen biosynthetic gene cluster in several P. aeruginosa
serogroups (Dean et al., 1999; Raymond et al., 2002). It
initiates the biosynthesis of both the common and the
serotype-specific LPS antigen by transferring GlcNAc-1-P
and FucNAc-1-P to undecaprenol-P (Rocchetta et al.,
1998; Belanger et al., 1999). Some serotypes of P. aeruginosa
have QuiNAc in their O-antigen and may possess a
WbpL-like transferase that uses UDP-QuiNAc as the
sugar nucleotide substrate (DiGiandomenico et al., 2002;
Raymond et al., 2002).
Sequence analysis of the deduced WbpL/WbcO protein
sequences showed a topological arrangement similar to the
MraY and the WecA proteins (Anderson et al., 2000).
WbpL and WbcO, as well as the other members of their sub-
group, possess a highly conserved consensus sequence
unique to the whole subgroup (Anderson et al., 2000). This
WbpL/WbcO-specific sequence motif, YEAHRSHxYQx-
AxR, is situated within cytoplasmic domain V, similar to the
location of the MraY- and WecA-consensus motifs (Figure
1). Complementation analyses have shown that functional
mutations in the P. aeruginosa wbpL can be restored by the
E. coli wecA gene, but only for the biosynthesis of the com-
mon LPS (Rocchetta et al., 1999). This suggests that the
substrate specificity of the WecA protein does not extend
to either of the sugar nucleotides, UDP-QuiNAc or UDP-
FucNAc (Rocchetta et al., 1998; Belanger et al., 1999).
Genes homologous to wbcO/wbcL homologs are also
found on the genomes of other Pseudomonas and Yersinia
species. The wbiH gene of Burkholderia sp. (e.g.,
Q79TO2_BURMA and O69129_BURPS) and Azoarcus
(Q5P6P6) are assigned to the WbcO/WbpL family by CR
domain homology (Anderson et al., 2000). A WbcO/
WbpL subfamily member is also present in the recently
sequenced genome of Methylococcus capsulatus str. Bath,
where it has a potential role in the biosynthesis of an
insoluble capsule (Ward et al., 2004). The putative WbcO
protein encoded by this gene (Q60AG0) contains a
DDxxD-type motif, a conserved active site aspartyl
nucleophilic (145-FMGD-148), and a characteristic
YEAHRSHxYQxAxR CR domain typical of other
WbcO/WbpL subfamily members. However, it is consider-
ably smaller (hypothetical 274 residues, 28.7 kDa) than other
subfamily members and lacks a 60–70 residue N-terminal
domain (N. Price, unpublished).
The WbpL/WbcO consensus motif also shows sequence
similarity to another UDP-HexNAc: polyprenol-P trans-
ferase subfamily type, typified by the RgpG protein from
Streptococcus mutans (Anderson et al., 2000). RgpG is a
putative HexNAc-1-phosphate transferase which is
required for rhamnose–glucose polysaccharide (RGP) syn-
thesis (Yamashita et al., 1999). The rgpG gene can comple-
ment a wecA-deficient E. coli strain, which suggests a
functional similarity between the RgpG and the WecA pro-
teins (Yamashita et al., 1999). Based on sequence homology
in the cytoplasmic domain V, the RgpG CR domain
appears to be a hybrid that aligns with both the WecA and
the WbcO consensus motifs (Anderson et al., 2000).
CR domains
C-terminal cytoplasmically located CR domains have been
identified for the UDP-HexNAc: polyprenol-P HexNAc-1-P
transferase family that are unique to specific subfamily
members (Anderson et al., 2000). These CR domains typi-
cally consist of 28 residues that form a cytoplasmically
located loop (cytoloop V), which is highly basic (pI range
10–12) and is immediately adjacent to the active site of the
transferase at the membrane–cytoplasm interface.
There is an absolute correlation between the presence of
a particular cytoloop V and the UDP-N-acetyl-D-
hexosamine substrate specificity (Anderson et al., 2000;
Amer and Valvano, 2002). The MraY CR domain contains
a highly conserved, short internal sequence motif of 13
amino acids: MAPIHHHFELKGW (Anderson et al.,
2000) that is not found in any of the other subgroups within
the transferase family and correlates with the subfamily
usage of UDP-MurNAc-pp. Similarly, the WecA CR
domain consists of 13 conserved residues RRxxxGxSPFSP-
DxxHIHH and is unique to the WecA subfamily members,
which selectively use UDP-GlcNAc (Anderson et al., 2000;
Amer and Valvano, 2001, 2002). Mutational analysis of the
CR domain of E. coli WecA supports the hypothesis that it
is involved in the recognition of UDP-GlcNAc (Amer and
Valvano, 2002). Replacement of the entire 279-HIHH-282
motif by GGGG resulted in a 93% reduction of WecA
activity. A similar loss of activity was observed for a con-
servative WecAH279S point mutation, highlighting the
importance of the first His residue in the CR domain. These
mutations also reduced tunicamycin binding, by 90 and
85% (Amer and Valvano, 2002), suggesting that the initial
UDP-GlcNAc–WecA recognition might occur via the
UDP-HexNAc sugar motif. A less dramatic phenotype was
observed for a conservative Arg→Lys substitution of the
second Arg (Arg-265) at the start of the E. coli WecA CR
domain. This reduced the enzymatic activity by about 55%
and tunicamycin binding by a similar amount (Amer and
Valvano, 2002). Basic amino acid residues are also present
at the start of the CR domains for MraY and WbcO/WbpL
family members (Figure 1). It has been suggested that the
E. coli WecA Arg-265 could be involved in binding the acidic
phosphates of UDP-GlcNAc (Amer and Valvano, 2002),
although it is difficult to reconcile this with the binding of
UDP-GlcNAc:Mg2+ as a complex to the DDxxD motif on
cytoloop II (see discussion below). One plausible explana-
tion is that these basic residues help to stabilize the charge
on the HexNAc-PP-undecaprenol product or on the cova-
lent HexNAc-1-P: enzyme intermediate that is formed as a
consequence of the double displacement reaction mecha-
nism (Heydanek et al., 1969).
The WbcO/WbpL family members carry a WbcO-specific
cytoloop V that contains the conserved CR domain
YEAHRSHxYQxAxR, which potentially determines the
specificity for a third sugar nucleotide type, UDP-D-
FucNAc and/or UDP-D-QuiNAc (Anderson et al., 2000).
The CR domain of the RgpG subfamily has a hybrid
WecA–WbcO sequence. Complementation data for a rgpG-
deleted S. mutans (Yamashita et al., 1999) and the dual
nature of its CR domain predicted it to be capable of both
GlcNAc1-P and FucNAc-1-P transfer (Anderson et al., 2000).
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Although the CR domains for MraY, WecA, and WbpL/
WbcO have no homology at the sequence level, they are all
characterized by exceptionally high isoelectric points
(Anderson et al., 2000). They may interact selectively with
the acidic HexNAc-1-P: enzyme intermediates, as sug-
gested above. Alternatively, this interaction could be with
the next glycosyltransferase in the three respective biosyn-
thetic pathways, all of which have a presumed peripheral
membrane location (Hu et al., 2003; van den Brink-van der
Laan et al., 2003). The extent to which the CR domains
alone dictate transfer specificity will ultimately require the
construction of hybrid proteins whose defining cytoloop V
domains have been interposed with those from other
family members.
The catalytic mechanism and the DDxxD motif
Models of the membrane topology of MraY and WecA
have been proposed based on the localization of β-lactamase
and FLAG epitope inserts, respectively (Bouhss et al.,
1999; Amer and Valvano, 2001), and have been refined by
comparative sequence alignment of the transferase family
(Lehrman, 1994; Nogare et al., 1998; Anderson et al., 2000).
These studies implicate conserved sequence motifs on the
five cytoplasmic loops as the UDP-sugar binding site and
the catalytic site. Adjacent conserved aspartyl residues
located on loop II, D-115/D-116 for MRAY_ECOLI and
D-90/D-91 for WECA_ECOLI (Figure 3a), are postulated
to be part of a DDxxD motif and are potentially involved
in binding a Mg2+ cofactor (Amer and Valvano, 2002;
Lloyd et al., 2004; Xu et al., 2004).
Ashby and Edwards first noted DDxxD motifs as a con-
served feature of prenyltransferases and proposed that the
aspartates in these motifs bind diphosphate-containing sub-
strates through Mg2+ bridges (Ashby and Edwards, 1990).
Evidence supporting this comes from the X-ray crystal
structure of recombinant avian farnesyl diphosphate syn-
thase (FPS), which contains two DDxxD Asp-rich regions
(D-117 to D-121 and D-257 to D-261) located at the end of
α-helices D and H, respectively (Tarshis et al., 1994). Fur-
ther evidence arose from the binding of samarium heavy
metal atoms into the Mg2+-binding sites within the crystal
structure of avian FPS (Tarshis et al., 1994). The side
chains of D-117, D-118, D-121 and of D-257, D-258, D-261
are positioned so that their carboxylate groups all point
into the active site cleft. The DDxxD motif generally has a
basic residue (Arg or Lys), 10 residues downstream, which
is also implicated in binding the metal ion. For avian FPS,
these conserved basic residues (Arg-126 and Lys-271) were
found on the loops between helices D/E and helices H/I,
respectively.
Mutational studies have confirmed the importance of the
DDxxD motif for FPS (Joly and Edwards, 1993; Song and
Poulter, 1994) and for the D-GlcNAc-1-P transferases
(Amer and Valvano, 2002). A substitution mutation of the
first Asp in the DDxxD domain II of FPS to Glu decreased
the Vmax by over 90-fold, whereas mutation of the third
Asp had little effect (Joly and Edwards, 1993). The Michaelis
constant remained unchanged by either mutation (Joly and
Edwards, 1993). These results suggest that the first aspartate
in domain II is involved in the catalysis by FPS, but not in
substrate binding.
The Mg2+-binding DDxxD motif identified for E. coli
WecA is highly conserved for all of the HexNAc-1-P trans-
ferase family members (Lehrman, 1994; Anderson et al., 2000)
(Figure 3a). Hence, the 90-DDxxD-94 in WECA_ECOLI
corresponds to 115-DDxxK-119 for MRAY_ECOLI and
to 92-DDxxH-96 for the Y. enterocolitica WbcO sequence
(Figure 3). These motifs are invariably located on cytoplas-
mic loop II, and for the bacterial transferases are usually
43–45 residues downstream of the conserved Gly-Gly motif
at the C-terminal end of cytoloop I. Noticeably, although
the DD is invariably present, the adjacent region is not
especially conserved (Figures 1 and 3). Substitution muta-
tions that affect the DD motif in E. coli WecA or MraY
result in decreased enzymatic activities (Amer and Valvano,
2002; Lloyd et al., 2004), but substitution of the 3rd Asp
(i.e., D-94) in WecA resulted in no observable change.
These results are comparable with the mutational analysis
of the DDxxD domain II of FPS (Joly and Edwards, 1993)
and highlight the importance of the two adjacent DD residues.
Other conserved aspartyl residues are also implicated in
the HexNAc-1-P transferase catalytic process (Amer and
Valvano, 2002; Lloyd et al., 2004). Mutations in D-156 and
D-159 of E. coli WecA result in <10% of wild-type activity
and have significantly reduced binding to tunicamycin
Fig. 3. (a) The putative DDxxD motif for Chinese hamster ovary (CHO) 
cell UDP-GlcNAc: dolichol-P GlcNAc-1-P transferase (GPT) (P24140), 
Escherichia coli WecA (P24235), E. coli MraY (P15876), and Yersinia 
enterocolitica WbcO (Q9F8C9). The conserved Asp-Asp (highlighted in 
bold) are predicted to be coordinated to the Mg2+ cofactor, which forms 
ligands to the pyrophosphate moiety of the UDP-HexNAc sugar nucle-
otide substrate or to the 5′-OH, 8′-OH, and 7′-ring oxygen of the inhibitor 
tunicamycin (Lloyd et al., 2004; Xu et al., 2004). (b) The putative active 
site nucleophilic Asp V/IFMGD motif for CHO cell GPT (P24140), E. coli 
WecA (P24235), E. coli MraY (P15876), and Y. enterocolitica WbcO 
(Q9F8C9). Topology analyses map the conserved Asp to be five residues 
(highlighted in bold) inside the bilayer on the predicted transmembrane 
domain following cytoplasmic loop IV.
CLUSTAL W multiple sequence alignment 
sp|P24140|GPT_CRIGR    105-ICCMIFLGFADDVLNLRWRH-124 
sp|P24235|WECA_ECOLI    80-AGVLVFIGALDDRFDISVKI-99 
sp|P15876|MRAY_ECOLI   105-LVGYGVIGFVDDYRKVVRKD-124 
tr|Q9F8C9|WBCO_YEREN    82-GGVIALVGFWDDHGHIAARW-101 
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(Amer and Valvano, 2002). These two resides form part of
the highly conserved NxxNxxDGIDGL motif that is
located on cytoloop III for all the bacterial subfamily trans-
ferases (Figure 1). This indicates their probable role in cata-
lytic activity, with the reduced tunicamycin binding
suggesting a possible interaction with the UDP-HexNAc
(Amer and Valvano, 2002). However, because they are con-
served in all family members, including the eukaryotic GPT
proteins (Nogare et al., 1998), these residues are unlikely to
be directly involved in the UDP-HexNAc substrate speci-
ficity of the bacterial transferases.
The active site nucleophile
Site-specific mutagenesis at residue D-267 of the E. coli
MraY has also been shown to eliminate enzyme activity
(Lloyd et al., 2004). This led to the hypothesis that D-267 is
the active site nucleophile responsible for the cleavage of the
substrate pyrophosphate bond (Lloyd et al., 2004) (Figure 4).
The comparable aspartyl residue, D-252, of the CHO cell
GPT is highly conserved with other members of the MraY/
WecA/WbcO family (Figure 3b) and is also essential for
activity (Scocca and Krag, 1997). The hydrophobicity pro-
file of the CHO GPT sequence shows that Asp-252 is located
on TM-8, just inside the cytoplasmic side of the membrane
(Anderson et al., 2000) (Figures 1 and 3b). Hydrophobicity
analysis places the E. coli MraY Asp nucleophile (D-267)
identified by Lloyd et al. (2004) at five residues inside the
cytoplasmic face of TM-8. Topological analysis of the E. coli
MraY by blaM (β-lactamase) fusion insertion places this res-
idue on cytoloop IV between TM-7 and TM-8 (Bouhss et al.,
1999). However, it is noticeable that the transmembrane
domain TM-8 is predicted to contain only 14 residues
(Bouhss et al., 1999), typically too small a helix to traverse
the membrane bilayer. Moreover, the equivalent active site
Asp nucleophile for E. coli WecA (D-217) and for Y. entero-
colitica WbcO (D-215) are similarly placed five residues
inside of TM-8 (i.e., 213-VFMGD-217 and 211-IFMGD-
215, respectively) (Figure 3b) and are therefore also on the
transmembrane helix immediately after cytoloop IV.
The bacterial V/IFMGD motifs are highly conserved
with the equivalent region around Asp-286 in the CHO cell
GPT (248-VFVGD-252) and are believed to be the active
site nucleophile regions (Figure 3b). The terminal aspartyl
group in this motif undergoes nucleophilic attack on the
beta-phosphate of the UDP-HexNAc substrate, leading to
a displacement of UMP and to the formation of an acyl-
enzyme intermediate, in which the HexNAc-1-phosphate is
covalently attached to the active site Asp (Figure 4). This is
in agreement with the double displacement mechanism pro-
posed from kinetic studies on MraY (Heydanek et al., 1969;
Brandish et al., 1996a). Moreover, for E. coli MraY, the
predicted acyl-enzyme intermediate, MurNAc-pentapeptide-
1-P–MraY, has been trapped following the incubation of
solubilized MraY with radiolabeled UDP-MurNAc-
pentapeptide. The radiolabeled enzyme–substrate complex
was observed after gel filtration (Lloyd et al., 2004),
although unfortunately, the comparable experiment with
the E. coli MraY D-267 residue mutated was not reported.
Fig. 4. Generalized mechanism for the UDP-HexNAc: polyprenol-P 
HexNAc-1-P transferase enzyme family. (A.) UDP-D-HexNAc coordi-
nated via the Mg2+ cofactor to the DDxxD motif on cytoloop II and 
nucleophilic attack by active-site Asp located on cytoloop IV/TM-8. 
(B.) Displacement of UMP and formation of a HexNAc-phospho-acyl-
enzyme covalent intermediate. (C.) Nucleophilic attack by membrane-
associated polyprenol phosphate. (D.) Formation of the HexNAc-PP-
polyprenol product. The putative carbohydrate recognition (CR) domain 
located on cytoloop V is depicted by the blue cross-hatching.
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Enzyme inhibitor studies
Peptidoglycan biosynthesis is a well-documented target for
antimicrobial agents, and there are several antibiotics that
block the MraY-catalyzed step (Bugg and Walsh, 1992;
Kimura and Bugg, 2003). MraY inhibitors can be classified
based on their mode of inhibition, being either direct inhib-
itors of MraY, such as tunicamycin, or indirect inhibitors
such as amphomycin and bacitracin (Kimura and Bugg,
2003). Direct inhibitors contain pharmacophores that
mimic the nucleotide substrate and have additional hydro-
phobic moieties attached (Figure 5). Indirect inhibitors act
to limit the availability of the undecaprenol-P substrate by
interfering with its recycling.
Tunicamycin inhibits both MraY and GPT, which
account for its known bacterial and mammalian toxicity
(Heifetz et al., 1979; Brandish et al., 1996b). It reversibly
inhibits the transfer of MurNAc-pentapeptide-1-P to unde-
caprenol-P and the transfer of GlcNAc-1-P to undecapre-
nol-P or dolichol-P in bacterial or eukaryotic cells,
respectively (Tamura et al., 1976; Brandish et al., 1996b).
Several new classes of antibiotics have recently been charac-
terized as potent and specific inhibitors of the MraY-
catalyzed step in peptidoglycan assembly (Kimura and
Bugg, 2003). These compounds include mureidomycins
(Inukai et al., 1989; Isono and Inukai, 1991; Inukai et al.,
1993), liposidomycins (Isono et al., 1985; Muroi et al.,
1997), pacidamycins (Karwowski et al., 1989), napsamycins
(Chatterjee et al., 1994), muraymycins (Lin et al., 2002;
McDonald et al., 2002), FR-900493 (Kimura and Bugg,
2003), capuramycins (Yamaguchi et al., 1986), A-503083
(Muramatsu et al., 2004), and caprazamycins (Igarashi
et al., 2003). Like tunicamycin, these compounds share a
uridine nucleoside analog moiety found in the enzyme
sugar nucleotide substrate (Figure 5). In addition, the ϕX-
174 bacteriophage lysis protein E has been shown to inhibit
the MraY-type transferases by a direct interaction with a
periplasmic domain (Bernhardt et al., 2001).
Tunicamycin and mureidomycin inhibit the MraY and the
mammalian GPT transferases to varying extents (Heifetz
et al., 1979; Brandish et al., 1996b). Mureidomycin A is
>2000-fold more selective for the bacterial MraY MurNAc-
pp-1-P transferase, whereas tunicamycin is ∼1500-fold more
selective for the mammalian GlcNAc-1-P transferase
(Brandish et al., 1996b). Further, mureidomycin is a poor
inhibitor for the formation of lipid-linked N-acetylglu-
cosamine for TA synthesis in B. subtilis (IC50 > 100 µg/mL)
(Bouhss et al., 2004). Mureidomycin is competitive with
respect to both the fluorescent substrate analog dansyl-
UDP-MurNAc-pentapeptide and dodecaprenyl-P (Bouhss
et al., 2004). Tunicamycin acts as a competitive inhibitor
(Ki = 55 µM) with respect to the nucleotide substrate ana-
log dansyl-UDP-MurNAc-pentapeptide, but it is noncom-
petitive toward the lipid acceptor substrate, undecaprenol
phosphate. This suggests that the N-acyl chain of tunicamy-
cin may be involved in its localization to the membrane
layer rather than in binding to the active site of the enzyme
(Bouhss et al., 2004). In contrast, the inhibition of the
eukaryotic target enzyme GPT by tunicamycin has been
reported to be irreversible and noncompetitive with respect
to both substrates (Heifetz et al., 1979). Thus, the con-
served eukaryotic dolichol recognition sites in GPT
(Albright et al., 1989; Datta and Lehrman, 1993) may rep-
resent a potential binding site for the hydrophobic chain of
tunicamycin. In a screen for peptidoglycan, biosynthesis
inhibitors using permeabilized E. coli cells inhibition by tuni-
camycin was <25% at 50 µM, demonstrating the intrinsic
resistance of E. coli (Barbosa et al., 2002). In contrast, resis-
tance of E. coli to mureidomycin A and C is due to the
expression of the AcrAB-TolC multidrug efflux system
(Gotoh et al., 2003). Most Bacillus sp. are highly sensitive to
tunicamycin, and resistance in B. subtilis has been linked to a
specific gene, tmrB (Noda et al., 1992, 1995).
Mureidomycin A and liposidomycin B are both slow
binding inhibitors of E. coli MraY, with inhibition resulting
from either a reversible covalent interaction with the active
site or from the conversion of the E.I. complex into a more
tightly bound E.I.* state (Brandish et al., 1996a,b). Liposido-
mycin B is competitive with respect to the undecaprenol-P,
but noncompetitive with the sugar nucleotide, the reverse of
that seen for tunicamycin. Molecular modeling studies sug-
gest that when overlaid on a model of UDP-MurNAc-pen-
tapeptide, the lipid chains of liposidomycin and tunicamycin
align in different directions when the uracil fragments are
superimposed (Dini et al., 2000). This model also suggests that
the MurNAc analog of liposidomycin B and the GlcNAc resi-
due of tunicamycin superimpose, and that the pyrophosphate
unit of UDP-MurNAc-pentapeptide is mimicked by the
ribosamine ring of liposidomycin and the pseudogalac-
tosamine ring of tunicamycin. In this model, the 5′,2″-diazo-
panone ring of liposidomycin is aligned in the same direction
as the tunicamycin 5′-OH group (Dini et al., 2000).
The synthesis of a series of simplified pharmacophores
based on the nucleotide moiety of liposidomycin also
Fig. 5. Conformational alignment of a sugar nucleotide substrate (UDP-
D-GlcNAc) and several substrate analog inhibitors, tunicamycin, muray-
mycin, and capuramycin. The inhibitors share a uridine nucleoside analog 
moiety found in the sugar nucleotide substrate.
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highlights the importance of stereochemistry at the nucle-
otide 5′ position. For these synthetic 6-O-β-D-ribofuranosyl
nucleosides only the (S)-5′-hydroxymethyl isomer showed
significant activity against MraY (Dini et al., 2002). The
importance of the 5′ position was also probed, with primary
and secondary amino groups being 10–50 times more active
against MraY than amides or tertiary amino groups (Dini
et al., 2001a). Structure-activity relationship studies of
these analogs also pointed to the uracil ring as being crucial
and catalytic hydrogenation of the uracil 5,6-double bond
reduced the inhibitory activity by >20-fold (Dini et al., 2001a).
The presence of the 3″-hydroxy group was important to
retain activity, and further the 3′-deoxyribosyl uridinyl ana-
logs were even more active, being up to 5-fold more active
than the intact ribosyl analog (Dini et al., 2001b).
Inhibition of MraY has also been investigated using
5′-uridinyl dipeptide analogs based on mureidomycin (Gentle
et al., 1999; Howard and Bugg, 2003). A uridine 5′-alanine-
N-methyl-β-alanine ester showed greatest activity, with the
N-methyl group, a requirement for potent inhibition (Gentle
et al., 1999). Hence, the positively charged amine side chain
of mureidomycin A was proposed to bind directly to the
MraY DDxxD moiety, in lieu of the Mg2+ cofactor. In addi-
tion, inhibition of MraY by nucleoside analogs of mureido-
mycin can be relieved by Mg2+ suggesting a common binding
site within the enzyme (Howard and Bugg, 2003).
Further insight into the active site architecture of the
UDP-HexNAc: polyprenol-P HexNAc-1-P transferases has
come from consideration of the conformation of the sub-
strate analog tunicamycin (Xu et al., 2004). The conforma-
tional flexibility of tunicamycin is somewhat constrained by
its four ring systems (Figure 6). Mobility is restricted to the
1″,11′-glycosidic linkage between the A and B rings, the
6′-methylene bridge between the B and C rings, and to
restricted rotation about the N-glycosidic linkage to the
uracil (ring D). Nuclear magnetic resonance (NMR)-derived
through bond proton couplings from the uracil H-6 to the
tunicamycin H-2′, H-3′, and H-5′ protons established that
the pseudoribosyl ring assumes an endo-2′-exo-3′ puckered
conformation with the uracil group anti-aligned (Xu et al.,
2004). Similar couplings from the tunicamycin H-11′ to H-7′
and H-9′ protons assigned the structure of the pseudogalac-
tosamine pyranose ring as having a 4C1 chair conformation,
in which the N-acyl group is extended from the back face
(Figures 6 and 7). The pseudogalactosamine pyranose ring
is presumed to mimic the pyrophosphate linkage of the
sugar nucleotide within the enzymatic active site.
The conformational state about the 6′-methylene bridge
was rationalized by the preparation of chirally deuterated
tunicamycin (Xu and Price, 2004; Xu et al., 2004). Strepto-
myces chartreusis, a tunicamycin-producing streptomycete
was cultured on medium containing chemically synthesized
(S)-D-(6-2H)-glucose, resulting in deuterium incorporation at
the 6″-methylene of the GlcNAc (ring A) and 6’-methylene in
the 6′-methylene bridge (Xu et al., 2004). NMR correlation
spectroscopy (COSY and HSQC) of the resultant chirally
labeled (R)-(6′-2H) 6′-methylene bridged tunicamycin
assigned H-7′–H-6′a, H-6′b–H-5′, and H-5′–H-4′ as coupled
systems. Newman projections of the C-7′–C-6′, C-6′–C-5′,
and C-5′–C-4′ bonds were consistent with the NMR data
and predicted a C-5′(+), C-6′(+), and C-7′(+) bridge
conformation (Xu et al., 2004). Molecular modeling by the
authors indicates that this arrangement facilitates the chela-
tion of divalent metal ions to the 5′-OH, 8′-OH, and the
pseudogalactosamine ring ether oxygen 7′-O, and weaker
interactions with the A ring of tunicamycin (Figure 7).
Mg2+ has a strong propensity to assume octahedral coordi-
nation, with the average distance of 2.1 angstroms between
the Mg2+ and coordinating oxygen atoms (Weber et al.,
1998). Molecular dynamics simulations of the tunicamycin
(R)-5′-hydroxymethyl epimer in a periodic box of water
molecules showed that a totally different extended confor-
mation was taken that persisted throughout the simulation
(Figure 6). This result suggests that the 5′-epimer of tunica-
mycin may never arrive at a conformation that is recognized
Fig. 6. Energy-minimalized conformational differences for native tunica-
mycin [S]-5′-hydroxy epimer and its [R]-5′-hydroxy epimer. Conformation 
flexibility is confined by the four ring systems, N-acetylglucosamine, 
pseudogalactosamine, pseudoribose, and uracil (rings A, B, C, and D, 
respectively). The epimeric 5′-carbon is indicated by an arrow.
Fig. 7. Conformation of tunicamycin with Mg2+ coordinated to positions 
5′-OH, 8′-OH, and the pseudoGalN pyranosyl ring 7′-O. The deduced 
O–Mg2+ coordination distances shown are energy minimalized and in 
accordance with those in the catalytic sites of F1-ATPase (Weber et al., 
1998).
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by the receptor protein, or is incorrectly folded when com-
plexed with Mg2+ and so does not bind. Consistent with
our model of tunicamycin binding to the Mg2+ cofactor,
tunicamycin–metal complexes were identified by matrix-
assisted laser desorption/ionization time-of-flight (MALDI-
TOF) mass spectroscopy, including a Mg2+–tunicamycin
complex and a dimeric complex of Mg2+–(tunicamycin)2
(Xu et al., 2004).
The coordination of Mg2+ to the tunicamycin structural
motif implicated in mimicking the pyrophosphate linkage
of UDP-HexNAc suggests a probable mechanism for its
inhibition of the UDP-HexNAc: polyprenol-P HexNAc-1-P
transferases family of enzymes. Tunicamycin may be coor-
dinated to the Mg2+ cofactor which is in turn ligated to the
Asp-Asp of the transferase DDxxD motif (Figure 8). This
arrangement would block the binding of the UDP-HexNAc
substrate to the active site, thereby causing reversible inhi-
bition of the displacement mechanism at the first step. This
proposed mechanism is consistent with the known double
displacement kinetics of the transferases, the absolute
requirement for Mg2+ cofactor, and for the well-defined
UMP exchange reaction catalyzed by the transferases. More-
over, the proximity of the tunicamycin GlcNAc moiety (ring
A) to the transferase CR domain in this model suggests that
the sugar-nucleotide substrate recognition is mediated by this
interaction. Hence, the CR domain on cytoloop V may
determine the specificity for the UDP-HexNAc substrate
before its coordination to the DDxxD motif. The rational
design of selective inhibitors for MraY, WecA, WbcO, and
RgpG remains a laudable goal of antibiotic research.
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